0000000000266103

AUTHOR

Karlis Strenge

showing 5 related works from this author

TCT-361 Heart Team Approach to CAD Management in Patients Undergoing Elective Vascular Surgery Who Have Asymptomatic Ischemia-producing Coronary Sten…

2018

Patients undergoing peripheral vascular surgery (PVS) are at increased risk of post-op MI/death due to unrecognized CAD. Coronary CTA-derived fractional flow reserve (FFRCT) reliably identifies lesion-specific ischemia (LSI) in stable chest pain patients but has not been used in PVS patients. We

medicine.medical_specialtybusiness.industryIschemiaCADFractional flow reserveVascular surgeryChest painmedicine.diseasePeripheralInternal medicineHeart teamcardiovascular systemmedicineCardiologyIn patientcardiovascular diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of the American College of Cardiology
researchProduct

Plaque and blood vulnerability in ST segment elevation myocardial infarction patients: association between lesion morphology using intravascular ultr…

2013

AIM The purpose of the study was to evaluate associations between iMap intravascular ultrasound tissue characterization of culprit and nonculprit lesions in infarct-related artery and plasma biomarkers during ST segment elevation myocardial infarction (STEMI) and at 10-month follow-up. METHODS AND RESULTS Sixty-three STEMI patients at the time of index hospitalization and 10-month follow-up underwent coronary angiography and intravascular ultrasound with iMap tissue characterization of the culprit artery. Proximal and culprit segments were analyzed. A higher percentage of necrotic tissue in the nonculprit segment was found in patients in the top soluble intercellular adhesion molecule 1 (sI…

MaleAcute coronary syndromemedicine.medical_specialtyTime FactorsMyocardial InfarctionCoronary AngiographyCulpritLesionchemistry.chemical_compoundNecrosisPercutaneous Coronary InterventionPredictive Value of TestsInternal medicineIntravascular ultrasoundPlasminogen Activator Inhibitor 1medicineST segmentHumansMyocardial infarctionProspective StudiesUltrasonography InterventionalAgedmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseIntercellular Adhesion Molecule-1Coronary VesselsFibrosisPlaque Atheroscleroticmedicine.anatomical_structureTreatment OutcomechemistryPlasminogen activator inhibitor-1CardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersArteryCoronary artery disease
researchProduct

Carotid artery stenting outcomes in high-risk patients receiving best medical therapy: results from a single high-volume interventional cardiology pr…

2016

Kontext: Implantace stentů do karotických tepen (carotid artery stenting, CAS) se v soucasnosti ve velkem měřitku použiva v lecbě stenozy karotických tepen. Klinicke studie z posledni doby prokazaly nizkou incidenci přihod po CAS. Tato studie hodnoti 30denni a rocni výsledky pacientů lecených pro CAS intenzivni farmakoterapii na pracovisti provadějicim vysoke pocty perkutannich koronarnich intervenci rocně.Metoda: V obdobi od ledna 2011 do prosince 2013 byla CAS provedena celkem u 184 pacientů. Mimo protidestickove lecby byla provaděna i intenzivni antihypertenzni lecba spolu s vysoce intenzivni terapii statiny a lecbou zaměřenou na normalizaci srdecni frekvence. Pacienti byli stratifikovan…

medicine.medical_specialtyHigh risk patientsInterventional cardiologybusiness.industryCarotid arteries030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineCarotid artery diseaseMedicineCardiology and Cardiovascular MedicinebusinessNuclear medicineMedical therapy030217 neurology & neurosurgeryCor et Vasa
researchProduct

Tissue characteristics in non-culprit lesions during the acute coronary event and at ten months follow-up

2013

Introduction: It is not well established how the medication recommended in the guidelines will affect plaque compositional changes in non-culprit segments after STEMI. We hypothesized that the proportion of necrotic tissue in the non-culprit lesion in the culprit artery would decrease ten months after STEMI. Methods: In 63 consecutive STEMI patients the non-culprit segment in the culprit artery was analyzed with iMap intravascular ultrasound (IVUS) at the time of the index procedure and 10 months later. The non-culprit segment was identified as being 20mm proximal to the most stenotic culprit segment. All patients were recommended to receive the drug therapy outlined in the STEMI guidelines…

medicine.medical_specialtyNecrosisCoronary eventmedicine.diagnostic_testbusiness.industryCulpritSurgeryLesionPharmacotherapyCulprit arteryInternal medicineCulprit lesionIntravascular ultrasoundmedicineCardiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Tissue characterization comparison of culprit lesions between stable coronary disease and ST elevation myocardial infarction patients

2013

medicine.medical_specialtyNecrosisbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionTissue characterizationCoronary diseasemedicine.diseaseCulpritAtheromaSt elevation myocardial infarctionInternal medicineFactor V LeidenmedicineCardiologyRadiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct